Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prostate cancer

  • You have access
    In Vitro Cultivation of Primary Prostate Cancer Cells Alters the Molecular Biomarker Pattern
    ANNE CASPAR, JÖRG MOSTERTZ, MERLE LEYMANN, PATRICK ZIEGLER, KATJA EVERT, MATTHIAS EVERT, UWE ZIMMERMANN, LARS-OVE BRANDENBURG, MARTIN BURCHARDT and MATTHIAS B. STOPE
    In Vivo September 2016, 30 (5) 573-579;
  • You have access
    Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation
    MARVIN RUBENSTEIN, COURTNEY M. P. HOLLOWELL and PATRICK GUINAN
    In Vivo November 2015, 29 (6) 687-693;
  • You have access
    Inhibition of Cell Growth of the Prostate Cancer Cell Model LNCaP by Cold Atmospheric Plasma
    MARTIN WEISS, DENIS GÜMBEL, NADINE GELBRICH, LARS-OVE BRANDENBURG, ROBERT MANDELKOW, UWE ZIMMERMANN, PATRICK ZIEGLER, MARTIN BURCHARDT and MATTHIAS B. STOPE
    In Vivo September 2015, 29 (5) 611-616;
  • You have access
    Use of Tanning Potential as a Predictor for Prostate Cancer Risk in African-American Men
    DESTA BEYENE, MOHAMMAD DAREMIPOURAN, VICTOR APPREY, ROBERT WILLIAMS, LUISEL RICKS-SANTI, OLAKUNLE O. KASSIM, TAMMEY J. NAAB, YASMINE M. KANAAN and ROBERT L. COPELAND
    In Vivo November 2014, 28 (6) 1181-1187;
  • You have access
    Additional Compensatory Mechanisms Altering Antisense Oligonucleotide Suppression of BCL2: Effects upon AKT1 and STAT3
    MARVIN RUBENSTEIN, COURTNEY M. P. HOLLOWELL and PATRICK GUINAN
    In Vivo September 2014, 28 (5) 867-870;
  • You have access
    Complementary Medicine Down-regulates Side-effects of Hormone Therapy in Prostate Cancer Patients
    JOSEF BEUTH, RUDOLF VAN LEENDERT, KIRSTEN PEMPELFORT, BERTHOLD SCHNEIDER, CHRISTINA GRUND and UDO ENGELMANN
    In Vivo September 2014, 28 (5) 979-982;
  • You have access
    No Compensation in CD44 Stem Cell Marker Following BCL-2 Suppression By Antisense Oligonucleotides
    MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN
    In Vivo March 2013, 27 (2) 251-256;
  • You have access
    No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity
    MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN
    In Vivo November 2012, 26 (6) 937-940;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
In Vivo

© 2022 In Vivo

Powered by HighWire